美股市场个股详情
THC 泰尼特
- 122.360
- +2.080+1.73%
收盘价 05/06 16:00 (美东)
- 123.190
- +0.830+0.68%
盘后 16:24 (美东)
119.52亿总市值4.75市盈率TTM
122.390最高价119.370最低价124.81万股成交量121.730今开120.280昨收1.51亿成交额1.41%换手率21.43市盈率(静)9768.30万总股本122.39052周最高3.46市净率108.49亿流通值51.04052周最低--股息TTM8866.29万流通股210.000历史最高--股息率TTM2.51%振幅3.120历史最低121.320平均价1股每手
泰尼特股票讨论区
登录发表评论
The landscape of U.S. equities is abuzz with anticipation as artificial intelligence (AI) cements its place as a transformative force in the technology sector. In a recent analysis by $高盛(GS.US$, optimism for AI integration remains robust, yet valuations steer clear of the vertiginous heights of previous market bubbles.
Goldman Sachs' insights reveal that market-implied long-term growth expectations hav...
Goldman Sachs' insights reveal that market-implied long-term growth expectations hav...
73
1
The significant stock sale by an insider at a lower price is seen as a negative signal. However, high insider ownership in Tenet Healthcare may indicate the company's interest in all shareholders. The absence of insider buying over the past year, despite profitability and growth, could be worrying.
Insider selling of Tenet Healthcare's stock below current price is discouraging, suggesting satisfaction with lower valuation. High insider ownership is positive, indicating alignment with shareholders. Yet, lack of recent insider buying and selling activity prompts caution.
Tenet Healthcare's respectable ROE is overshadowed by its high debt level, increasing risk and limiting future options. A high ROE without debt signifies a high-quality business. Between two companies with equal ROE, the less indebted one is preferred.
Despite a positive earnings outlook for Tenet Healthcare, unseen threats seem to be impacting its P/E ratio. Investors expect potential future earnings volatility, with some warning signs indicating uncertain company performance.
Insider selling implies low confidence in Tenet Healthcare's potential. High insider ownership indicates alignment with shareholders, but frequent selling and no buying warns of caution.
The acquisition is regarded as a long-term investment for healthcare across Novant Health's regions. Both companies express optimism about the benefits of this partnership, emphasizing their commitment to providing high-quality patient-focused care and enhancing access to healthcare services.
Despite a recent slump, long-term growth and transition to profitability signify sound business quality. With a recent 40% total shareholder return, the stock is worth considering.
$泰尼特(THC.US$营收5年来波动中变化不大，基本在185亿上下波动，营业利润连续5年增长，平均增速11.7%，净利润则受其它净收入/费用影响较大，近4年平均增速为16.9%。
2023Q1营收增长5.8%，营业利润下滑11.6%，净利润受其它净收入影响反而增长了5.7%。目前市盈率20.9，市盈率TTM略降到20.7，虽然和增速相比有一定的折扣，但是营收增长乏力的情况下单靠优化运营效率的增长毕竟是有限的，估值缺乏吸引力。
2023Q1营收增长5.8%，营业利润下滑11.6%，净利润受其它净收入影响反而增长了5.7%。目前市盈率20.9，市盈率TTM略降到20.7，虽然和增速相比有一定的折扣，但是营收增长乏力的情况下单靠优化运营效率的增长毕竟是有限的，估值缺乏吸引力。
暂无评论
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
Chen Kiat : Very informative